Bharati R Dhruva

Array ( [id] => 6110329 [patent_doc_number] => 20020172663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Localized myocardial injection method for treating ischemic myocardium' [patent_app_type] => new [patent_app_number] => 10/057409 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5609 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172663.pdf [firstpage_image] =>[orig_patent_app_number] => 10057409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6559648 [patent_doc_number] => 20020164648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Methods and compositions for delivery and retention of active agents to lymph nodes' [patent_app_type] => new [patent_app_number] => 10/044650 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17293 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164648.pdf [firstpage_image] =>[orig_patent_app_number] => 10044650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056428 [patent_doc_number] => 20050277603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof' [patent_app_type] => utility [patent_app_number] => 10/220824 [patent_app_country] => US [patent_app_date] => 2002-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8175 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277603.pdf [firstpage_image] =>[orig_patent_app_number] => 10220824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7447023 [patent_doc_number] => 20040186068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Growth hormone transcription factor' [patent_app_type] => new [patent_app_number] => 10/032438 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4656 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186068.pdf [firstpage_image] =>[orig_patent_app_number] => 10032438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6650924 [patent_doc_number] => 20030008375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Methods for treating patients with adenoviral vectors' [patent_app_type] => new [patent_app_number] => 10/033491 [patent_app_country] => US [patent_app_date] => 2001-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 32950 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008375.pdf [firstpage_image] =>[orig_patent_app_number] => 10033491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113211 [patent_doc_number] => 20020173634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggybac' [patent_app_type] => new [patent_app_number] => 10/001189 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 139 [patent_figures_cnt] => 139 [patent_no_of_words] => 9716 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173634.pdf [firstpage_image] =>[orig_patent_app_number] => 10001189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921561 [patent_doc_number] => 20020115059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Drug screening system' [patent_app_type] => new [patent_app_number] => 10/045721 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6869 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115059.pdf [firstpage_image] =>[orig_patent_app_number] => 10045721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7617148 [patent_doc_number] => 06946292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-20 [patent_title] => 'Cells producing antibody compositions with increased antibody dependent cytotoxic activity' [patent_app_type] => utility [patent_app_number] => 09/971773 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 73 [patent_no_of_words] => 77386 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946292.pdf [firstpage_image] =>[orig_patent_app_number] => 09971773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615687 [patent_doc_number] => 20020064769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Dynamic visualization of expressed gene networks in living cells' [patent_app_type] => new [patent_app_number] => 09/968864 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8075 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064769.pdf [firstpage_image] =>[orig_patent_app_number] => 09968864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 465996 [patent_doc_number] => 07235233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts' [patent_app_type] => utility [patent_app_number] => 10/381857 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 14932 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235233.pdf [firstpage_image] =>[orig_patent_app_number] => 10381857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873415 [patent_doc_number] => 20020048566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Modulation of cellular apoptosis and methods for treating cancer' [patent_app_type] => new [patent_app_number] => 09/950836 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22140 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048566.pdf [firstpage_image] =>[orig_patent_app_number] => 09950836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788458 [patent_doc_number] => 20020160971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor' [patent_app_type] => new [patent_app_number] => 09/953572 [patent_app_country] => US [patent_app_date] => 2001-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5133 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160971.pdf [firstpage_image] =>[orig_patent_app_number] => 09953572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397536 [patent_doc_number] => 20040038919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Novel gene therapy agent for haemophilia b and its preparation method' [patent_app_type] => new [patent_app_number] => 10/362916 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7058 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038919.pdf [firstpage_image] =>[orig_patent_app_number] => 10362916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739696 [patent_doc_number] => 20030157065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Tumor-specific promoters' [patent_app_type] => new [patent_app_number] => 10/333013 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9032 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157065.pdf [firstpage_image] =>[orig_patent_app_number] => 10333013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496003 [patent_doc_number] => 20020025307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues' [patent_app_type] => new [patent_app_number] => 09/884098 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32729 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025307.pdf [firstpage_image] =>[orig_patent_app_number] => 09884098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813244 [patent_doc_number] => 20030072794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Encapsulation of plasmid DNA (lipogenes) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes' [patent_app_type] => new [patent_app_number] => 09/876904 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31892 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072794.pdf [firstpage_image] =>[orig_patent_app_number] => 09876904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7352601 [patent_doc_number] => 20040048379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution' [patent_app_type] => new [patent_app_number] => 10/276602 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17819 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048379.pdf [firstpage_image] =>[orig_patent_app_number] => 10276602 [rel_patent_id] =>[rel_patent_doc_number] =>)